obesity-995x60.png
FEATURED ARTICLES
The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026
Antimicrobial resistance (AMR) has increasingly worried public health officials and researchers alike in 2025. Now, in 2026, TAXI Pharmaceutical President and CEO Gregory C. Mario, MBA, is calling for more targeted approaches and the integration of AI for quicker discovery and development.
-
Preparing Clinical Teams for 2026: AI, Automation & Integration
Clinical teams should prepare for 2026 by embracing AI, automation, and unified platforms to improve efficiency, data quality, and scalability in increasingly complex trials.
-
Clinical Data Modernization: A 2026 Starter Guide
Clinical data modernization replaces outdated systems with integrated cloud solutions, improving data quality, accelerating insights, and streamlining workflows for more efficient trials.
-
At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.